Loading the section
The price of TransMedics Group, Inc. (TMDX) on October 9, 2026 is 77.87 USD, -1.43% on the day. Over 52 weeks the stock traded between 60.10 USD and 156.00 USD; the price now sits 19% of the way up that range. Over the past year the price changed by -34.04%. The P/E ratio is 15.6, which is below the sector median (24.8). Market capitalization is 2.69 billion USD, rank 4 among 21 stocks of the same industry with a known capitalization.
Closing prices for 09 October 2026
Next earnings report: 04 November 2026 · Earnings calendar
TransMedics Group, Inc. trades on Nasdaq under the ticker TMDX. The company belongs to the Health care sector. The trading history on this page starts on 02 May 2019.
Over the past 52 weeks TMDX has traded between 60.11 $ and 156.00 $. As of 09 October 2026 the price stood 18.53 % of the way from the 52-week low to the high.
Over one year TMDX shares fell 34.04 %; over six months they fell 31.69 %. Volatility over 90 days is 50.36 %. Dividends are not included: this is price change only, as of 09 October 2026.
TMDX trades at a price-to-earnings ratio of 15.6, below the sector median of 24.8. Price to sales is 4.2, above the sector median of 3.9. Price to book is 5.4, above the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 79.13 | 81.33 | 76.86 | 77.87 | 733,651 |
| 08 October 2026 | 80.25 | 80.28 | 77.50 | 79.00 | 949,400 |
| 07 October 2026 | 80.96 | 83.90 | 80.56 | 81.07 | 962,600 |
| 06 October 2026 | 83.87 | 84.05 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
TransMedics Group, Inc. (TMDX) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, revenue was 605.5m $, net income was 190.3m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:200 MINUTEMAN ROAD, ANDOVER, MA, 01810, US
TransMedics Group, Inc. reported revenue of 636M $ and net income of 172M $ over the last four quarters. Net margin is 27.04 %. Revenue changed by +30.24 % year over year. Earnings per share are 4.37 $. Market capitalisation is 2.7B $.
TMDX has a return on equity of 34.80 %, above the sector median of −41.68 %. Return on assets is 11.98 %, above the sector median of −32.11 %. Operating margin is 14.85 %, above the sector median of −26.84 %.
| 49M |
| NXLNexalin Technology, Inc. | 3.63 | −11.68 % | 16M |
| CNMDCONMED Corporation | 44.42 | −1.53 % | 16M |
| CBLLCeriBell, Inc. | 23.06 | −0.41 % | 8M |
| INMDInMode Ltd. | 14.19 | +0.78 % | 7M |
| 80.08 |
| 80.28 |
| 570,700 |
| 05 October 2026 | 79.50 | 83.40 | 77.37 | 82.99 | 994,900 |
| 02 October 2026 | 79.81 | 80.85 | 77.14 | 79.80 | 1M |
| 01 October 2026 | 83.92 | 84.24 | 78.02 | 78.64 | 880,100 |
| 30 September 2026 | 84.87 | 84.87 | 81.55 | 83.45 | 566,600 |
| 29 September 2026 | 82.56 | 84.22 | 81.76 | 84.07 | 440,200 |
| 28 September 2026 | 86.38 | 86.38 | 82.70 | 82.73 | 422,500 |
| 25 September 2026 | 83.50 | 85.69 | 81.80 | 85.29 | 696,700 |
| 24 September 2026 | 86.09 | 86.09 | 82.53 | 83.90 | 623,700 |
| 23 September 2026 | 88.22 | 89.19 | 85.07 | 87.00 | 615,600 |
| 22 September 2026 | 88.15 | 89.80 | 86.50 | 88.07 | 750,700 |
| 21 September 2026 | 87.35 | 89.53 | 86.75 | 87.29 | 590,800 |
| 18 September 2026 | 87.18 | 87.98 | 85.01 | 86.42 | 1M |
| 17 September 2026 | 88.00 | 89.41 | 85.47 | 86.66 | 690,600 |
| 16 September 2026 | 88.17 | 88.28 | 86.29 | 87.56 | 464,700 |
| 15 September 2026 | 86.39 | 90.67 | 85.47 | 88.09 | 942,800 |
| 14 September 2026 | 82.62 | 88.49 | 80.59 | 85.86 | 942,900 |